Why New Coronavirus Strains Could Boost Pfizer and Moderna's Fortunes

The obvious question on many people's minds is: Will the vaccines from Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) that are already being distributed in the U.S. still be effective against the new strain? So far, the answer to that question appears to be "yes." However, more research is being conducted.

While all of this is understandably concerning, there's a silver lining for some investors. Here's why the coronavirus strains could actually boost Pfizer and Moderna's fortunes.